Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liver cirrhosis treated by living donor liver transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA.

Clinica chimica acta; international journal of clinical chemistry - 23 Sept 2013

Kondo Yuichi, Usui Hiromi, Ishige-Wada Mika, Murase Toshio, Owada Misao, Okubo Minoru

Abstract excerpt

Glycogen storage disease type III (GSD III) is an inherited disorder characterized by the accumulation of abnormal glycogen in the liver. Hepatic manifestations were considered as improving with age; however, patients live longer and liver cirrhosis is being recognized. We report a patient of GSD IIIa with liver cirrhosis, which was treated successfully by living donor liver transplantation. The patient proved to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Glucosidases
Share to Heterozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Living Donors

Share to Mutation

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 23688858
DOI: 10.1016/j.cca.2013.05.007

Genes

AGL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liver cirrhosis treated by living donor liver transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA.PMID 23688858Read ↗

Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.Semantic proximity Read ↗

Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.Semantic proximity Read ↗

Molecular characterization of glycogen storage disease type III.Semantic proximity Read ↗

A Rare Case of Glycogen Storage Disease Type IIIa with a Novel Homozygous AGL Splice Variant in a Two-Year-Old Female born out of Consanguineous MarriageSemantic proximity Read ↗

A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme GeneSemantic proximity Read ↗

Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.Semantic proximity Read ↗

Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.Semantic proximity Read ↗

[Analysis of two cases of glycogen storage disease type III due to compound heterozygous variants of AGL gene].Semantic proximity Read ↗

Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.Semantic proximity Read ↗

Novel variants in Turkish patients with glycogen storage disease.Semantic proximity Read ↗

Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.Semantic proximity Read ↗

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.